CN Patent

CN1867322B — 结晶形式的γ-氨基丁酸类似物

Assigned to XenoPort Inc · Expires 2014-06-25 · 12y expired

What this patent protects

提供了结晶形式的γ-氨基丁酸类似物及其制备方法。

USPTO Abstract

提供了结晶形式的γ-氨基丁酸类似物及其制备方法。

Drugs covered by this patent

Horizant (GABAPENTIN ENACARBIL) · Azurity

Patent Metadata

Patent number: CN1867322B
Jurisdiction: CN
Classification: —
Expires: 2014-06-25
Drug substance claim: No
Drug product claim: No
Assignee: XenoPort Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.